Reporte zur Charge EL9266/EL8982

Symptomtext

sore arm; Muscle aches; Chills; The initial case was missing the following minimum criteria: no adverse effect. Upon receipt of follow-up information on (15Mar2021), this case now contains all required information to be considered valid. This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) reported that a 73-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9266/EL8982), via an unspecified route of administration in the left arm on an unspecified date at 9:45 am, as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162b2 on an unspecified date and experienced sore arm. The patient experienced sore arm, muscle aches and chills on an unspecified date. The seriousness criteria of the events were reported as non-serious by the health authority. The outcome of the events was recovered on an unspecified date. Follow-up attempts are completed. No further information is expected.